论文部分内容阅读
药用生物资源是我国中医药发展的物质基础,对保障人民健康和民族繁衍有着不可忽视的作用。但无序开发导致了一些中药物种濒危,中药资源生物多样性受到破坏。《吕氏春秋·义赏》说:“竭泽而渔,岂不获得,而明年无鱼;焚薮而田,岂不获得,而明年无兽”。中国在总量上是资源大国,而人均占有量远落后于西方发达国家。近20年来我国中成药及相关工业快速发展,产值年平均增长20%以上
Medicinal biological resources are the material basis for the development of Chinese medicine in China and have a non-negligible role in protecting people’s health and national reproduction. However, disorderly development has led to the endangerment of some species of traditional Chinese medicine and the destruction of biodiversity of traditional Chinese medicine resources. “Lu’s Spring and Autumn Rewards” said: “I would like to do my fish and fish, I won’t get it, and I won’t have any fish next year. I’ll burn it and I won’t get it, but I won’t have a beast next year.” China is a large country in terms of total resources, and its per capita share lags far behind that of Western developed countries. In the past 20 years, Chinese proprietary Chinese medicines and related industries have developed rapidly, and the average annual output value has increased by more than 20%.